AMA
Wieczór R, Budzyński J, Pulkowski G, Rość D. Will determining the plasma vascular endothelial growth factor provide a valuable parameter for the assessment of patients with lower extremity artery disease in a General Practitioner’s practice? – a pilot study. Family Medicine & Primary Care Review. 2015;17(2):131-135.
APA
Wieczór, R., Budzyński, J., Pulkowski, G., & Rość, D. (2015). Will determining the plasma vascular endothelial growth factor provide a valuable parameter for the assessment of patients with lower extremity artery disease in a General Practitioner’s practice? – a pilot study. Family Medicine & Primary Care Review, 17(2), 131-135.
Chicago
Wieczór, Radosław, Jacek Budzyński, Grzegorz Pulkowski, and Danuta Rość. 2015. "Will determining the plasma vascular endothelial growth factor provide a valuable parameter for the assessment of patients with lower extremity artery disease in a General Practitioner’s practice? – a pilot study". Family Medicine & Primary Care Review 17 (2): 131-135.
Harvard
Wieczór, R., Budzyński, J., Pulkowski, G., and Rość, D. (2015). Will determining the plasma vascular endothelial growth factor provide a valuable parameter for the assessment of patients with lower extremity artery disease in a General Practitioner’s practice? – a pilot study. Family Medicine & Primary Care Review, 17(2), pp.131-135.
MLA
Wieczór, Radosław et al. "Will determining the plasma vascular endothelial growth factor provide a valuable parameter for the assessment of patients with lower extremity artery disease in a General Practitioner’s practice? – a pilot study." Family Medicine & Primary Care Review, vol. 17, no. 2, 2015, pp. 131-135.
Vancouver
Wieczór R, Budzyński J, Pulkowski G, Rość D. Will determining the plasma vascular endothelial growth factor provide a valuable parameter for the assessment of patients with lower extremity artery disease in a General Practitioner’s practice? – a pilot study. Family Medicine & Primary Care Review. 2015;17(2):131-135.
